The document outlines the creation of CENAFyT and its new role in coordinating and improving the monitoring of the safety of medicines in Mexico.

This document covers the following information:

  • CENAFyT’s responsibility for overseeing pharmacovigilance activities related to medicines
  • Strengthening of reporting, supervision, and investigation of adverse drug reactions
  • Updating and enforcing technical regulations, specifically NOM-220-SSA1-2016 for medicine safety
  • Coordination among all members of the National Pharmacovigilance System to ensure effective detection and management of risks associated with medicines
  • Commitment to protecting public health by ensuring that all medicines on the market are safe and effective

Consult Now

Source
https://www.gob.mx/cofepris/es/articulos/surge-el-centro-nacional-de-farmacovig…
Select Mandate HA
COFEPRIS
Select Mandate Function
Country Regulatory Affairs